ArticleNature communications2026
Phosphorescent supramolecular systems for medicine anticounterfeiting.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Realizing reliable medicine anticounterfeiting with safe and robust materials remains a challenge. We address this issue by preparing a class of edible phosphorescent supramolecules (VB10@α/β-CDs) based on easily available α/β-cyclodextrins (α/β-CDs) and vitamin B10 (VB10). Concisely grinding them with water or co-crystallization from aqueous solution, the resulting host-guest complexes VB10@α/β-CDs exhibit a long phosphorescence lifetime of up to 1.16 s and a high photoluminescent quantum yield of up to 86.5%, The encapsulation of α/β-CDs reverses the energy ordering of VB10's excited singlet states, promotes the formation of the minimum energy crossing point (MECP) between singlet state and triplet state, and therefore boosts phosphorescence. VB10@α/β-CDs are attractive as phosphorescent inks for in-medicine anticounterfeiting because of the advantages of an edible nature, good moisture robustness, room-temperature phosphorescence and circularly polarized luminescence. Therefore, the present phosphorescent supramolecules as well as the elucidated MECP-involved mechanism would promote in-depth understanding of phosphorescence enhancement strategy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.